Top compounds associated with response to TMEM79


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0085 0.8
mRNA CIL55A CTRPv2 pan-cancer AAC -0.012 0.8
mRNA TL-2-105 GDSC1000 pan-cancer AAC -0.0083 0.8
mRNA PHA-793887 CTRPv2 pan-cancer AAC 0.008 0.8
mRNA Merck60 CTRPv2 pan-cancer AAC 0.0076 0.8
mRNA BMS-536924 GDSC1000 pan-cancer AAC 0.0081 0.8
mRNA Platin CTRPv2 pan-cancer AAC -0.0092 0.8
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.0093 0.8
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.0094 0.8
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.0085 0.8
Download CSV